In addition to immunomodulatory activity, RSV prevents cancer development by affecting tumor microenvironment and inactivating essential pathways such as NF-kB, the mitogen-activated protein kinase (MAPK), and JAK/STAT that are essential for cancer cells’ development [40–42]. Here, NFKB1 is linked to cancer.